Economic burden and co-morbidities of atrial fibrillation in a privately insured population

By Wu Eric Q.   Birnbaum Howard G.   Mareva Milena   Tuttle Edward   Castor Adam R.   Jackman Warren   Ruskin Jeremy  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1693-1699

Informa Healthcare

Access to resources Recommend Favorite

Economic burden of psoriasis compared to the general population and stratified by disease severity

By Yu Andrew P.   Tang Jackson   Xie Jipan   Wu Eric Q.   Gupta Shiraz R.   Bao Yanjun   M. Mulani Parvez  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2429-2438

Informa Healthcare

Access to resources Recommend Favorite

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs*

By Birnbaum Howard G.   Ivanova Jasmina I.   Samuels Seth   Davis Matthew   Cremieux Pierre Y.   Phillips Amy L.   Meletiche Dennis  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 869-877

Informa Healthcare

Access to resources Recommend Favorite

Chronic gout: epidemiology, disease progression, treatment and disease burden

By Brook Richard A.   Forsythe Anna   Smeeding James E.   Lawrence Edwards N.  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2813-2821

Informa Healthcare

Access to resources Recommend Favorite

Assessing incidence and economic burden of genital warts with data from a US commercially insured population

By Hoy Tracey   Singhal Puneet K.   Willey Vincent J.   Insinga Ralph P.  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2343-2351

Informa Healthcare

Access to resources Recommend Favorite